Skip to main content

Table 5 PDAC meta-signature from the vote-counting strategy (reported consistently in at least five studies)

From: Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance

miRNA name

No. of studies

Mean fold-change

Mean rank

Up-regulated

   

hsa-miR-155

8

4.98

12.62

hsa-miR-21

7

2.95

12.29

hsa-miR-100

7

8.07

13.00

hsa-miR-221

7

6.71

11.42

hsa-miR-31

5

5.44

10.00

hsa-miR-10a

5

2.50

14.60

hsa-miR-23a

5

3.46

22.60

hsa-miR-143

5

4.03

9.40

hsa-miR-222

5

2.77

11.20

Down-regulated

   

hsa-miR-217

5

18.16

4.20

hsa-miR-148a

5

8.03

7.00

hsa-miR-375

5

4.86

9.40